Regulation of Transforming Growth Factor-β Type II Receptor Expression in Human Breast Cancer MCF-7 Cells by Vitamin D3and Its Analogues
Open Access
- 1 March 1998
- journal article
- Published by Elsevier
- Vol. 273 (13) , 7749-7756
- https://doi.org/10.1074/jbc.273.13.7749
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Down-regulation of the Cyclin A Promoter by Transforming Growth Factor-β1 Is Associated with a Reduction in Phosphorylated Activating Transcription Factor-1 and Cyclic AMP-responsive Element-binding ProteinPublished by Elsevier ,1997
- Defects of TGF-β receptor signaling in mammary cell tumorigenesisJournal of Mammary Gland Biology and Neoplasia, 1996
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995
- Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3Endocrinology, 1995
- Mechanism of activation of the TGF-β receptorNature, 1994
- Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containing four components of a Western-style dietCarcinogenesis: Integrative Cancer Research, 1994
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Pharmacodynamic and biological effects of anti-estrogens in different modelsJournal of Steroid Biochemistry, 1988
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987
- Preparation and binding of radioactively labeled porcine transforming growth factor type βBiochemical and Biophysical Research Communications, 1986